BlackRock
PVCT

BlackRock’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

BlackRock’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-900
Closed – – 3885
2016
Q3 		$0 Hold
900
– – ﹤0.01% 3793
2016
Q2 		$0 Hold
900
– – ﹤0.01% 3898
2016
Q1 		$0 Hold
900
– – ﹤0.01% 3791
2015
Q4 		$0 Buy
+900
New +$427 ﹤0.01% 3551

Other funds holding PVCT

CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
HFBOT
Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

BlackRock's PVCT Position: Q4 2016 in Review

BlackRock sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 900 shares.

BlackRock first reported a position in PVCT in Q4 2015 and held it in 4 quarters. The position peaked at $0 in Q3 2016. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

  • BlackRock reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
  • BlackRock sold 900 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016.
  • BlackRock first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q4 2015 and held it in 4 quarters.
  • BlackRock's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $0 in Q3 2016.
  • 8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on BlackRock's 13F filing for Q4 2016, filed 10 Feb 2017.